Meijsing Sebastiaan H, Pufall Miles A, So Alex Y, Bates Darren L, Chen Lin, Yamamoto Keith R
Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA 94158, USA.
Science. 2009 Apr 17;324(5925):407-10. doi: 10.1126/science.1164265.
Genes are not simply turned on or off, but instead their expression is fine-tuned to meet the needs of a cell. How genes are modulated so precisely is not well understood. The glucocorticoid receptor (GR) regulates target genes by associating with specific DNA binding sites, the sequences of which differ between genes. Traditionally, these binding sites have been viewed only as docking sites. Using structural, biochemical, and cell-based assays, we show that GR binding sequences, differing by as little as a single base pair, differentially affect GR conformation and regulatory activity. We therefore propose that DNA is a sequence-specific allosteric ligand of GR that tailors the activity of the receptor toward specific target genes.
基因并非简单地开启或关闭,相反,其表达会进行精细调节以满足细胞的需求。基因是如何被如此精确地调控的,目前还不太清楚。糖皮质激素受体(GR)通过与特定的DNA结合位点相结合来调节靶基因,不同基因的这些结合位点序列存在差异。传统上,这些结合位点仅被视为停靠位点。通过结构、生化和基于细胞的分析,我们发现GR结合序列之间哪怕仅相差一个碱基对,也会对GR构象和调节活性产生不同影响。因此,我们提出DNA是GR的序列特异性变构配体,它使受体的活性针对特定靶基因进行调整。